September 11th 2024
The FDA instead issued a CRL for MDMA-assisted psychotherapy for PTSD, requesting an additional phase 3 trial to examine safety and efficacy. Other psychedelic compounds are proceeding with trials for psychiatric conditions. Learn more here.
From Bath Salts to Spice and Beyond-Elucidating Emerging Drugs of Abuse
November 22nd 2012Spice, Bath Salts, and Salvia are emerging drugs of abuse, with patients increasingly turning to these agents. Since their legal status varies and they can be difficult to detect on standard drug tests, their popularity may be increasing.
Read More
The HEADS-ED: Review of a Mental Health Screening Tool for Pediatric Patients
November 6th 2012A new screening tool based on the previously developed mnemonic designed to assist physicians with obtaining a psychosocial history from adolescents as part of a routine visit was developed by researchers at the Children’s Hospital of Eastern Ontario.
Read More
Advances and Challenges in Treating Alcohol Dependence With Pharmacotherapy
November 2nd 2012Alcoholism is a chronic and serious disorder with often devastating consequences. One out of three families in the United States is negatively impacted by a family member's excessive drinking and painful drinking-related problems.
Read More
Alcohol Disorders: Practical Tips From New Research
September 8th 2012In this review, we discuss the established medications as well as experimental therapeutic options that may emerge as future medications for alcohol intoxication, withdrawal, and/or long-term abstinence maintenance or harm-reduced drinking.
Read More
Fighting the Wrong War on Drugs
August 30th 2012Seventy percent of antidepressants are prescribed by primary care doctors with little training in their proper use, under intense pressure from Big Pharma, drug salespeople, and misled patients, after rushed 7-minute appointments and subject to no systematic auditing. The cash-strapped FDA is beholden to industry for funding. And it gets worse.
Read More
Eliciting the Phenomenon of Schizophrenia From an Autobiographical Narrative
August 28th 2012In spite of a chronic mental illness (schizophrenia)and a psyche that increasingly blurred the boundaries between fantasy and reality, this lawyer and professor graduated from Vanderbilt with a perfect academic record.
Read More
Effects of New Antipsychotics and Adjunctive Therapy for Schizophrenia (Video: 4:05 minutes)
August 21st 2012What effect has the new antipsychotic Latuda had in patients with psychosis? Is a mood stabilizer as an adjunctive therapy necessary for schizophrenia or is the use of an antipsychotic alone sufficient?
Read More
Effective Personalized Strategies for Treating Bipolar Disorder
August 2nd 2012Effective personalized treatment recognizes bipolar disorder as a biopsychosocial disorder, but mood-stabilizing medications are the backbone of treatment. These medications fall into 3 categories: lithium, antikindling/antiepileptic agents, and second-generation antipsychotics.
Read More
Introduction: Dementia, Delirium, Depression, Drugs, and Driving
July 28th 2012Of the 3 informative articles included in this special geriatric collection, 1 offers a perspective on the treatment of depression that does not focus on somatotherapy. The others remind us of 2 additional geriatric Ds of importance: drugs and driving.
Read More
How to End a Psychiatric Epidemic: The Redemption of Psychiatry
June 12th 2012In light of our problems and uncertainties about the state of current psychiatry, or perhaps because of them, what might describe good psychiatry? Following are some suggestions for what we, as psychiatrists, can do.
Read More
Spitzer Recants: Why Can’t the APA Admit Mistakes and Correct Them?
May 31st 2012Let’s compare Dr Robert Spitzer's apology to the gay community with the stonewalling that has characterized every step in the development of DSM-5. The American Psychiatric Association has a lot to apologize for-but instead maintains a defensive posture that prevents insight and self-correction.
Read More